The Hon. Rauff Hakeem, Attorney-at-Law
Rauff Hakeem questioned reported irregularities in vaccine procurement and NMRA approvals, referring to the Health Minister’s earlier statement on the President’s Fund and the Speaker’s pledge to act against wrongdoing. He asked whether approvals had been granted exceptionally before orders were placed, while lower-priced suppliers were denied approval and favoured companies were selected, and demanded that the matter be investigated.
Verbatim record (translated)
Machine-translated from Sinhala / Tamil / English¶ 01 Mr. Speaker, my second supplementary is this. Yesterday, our Minister of Health gave a lengthy account regarding certain irregular actions related to the President’s Fund. You also promised to catch the thieves. Now, inquiries are revealing facts. Media reports stated that, as an exception, NMRA approvals were granted even before placing orders for some vaccines. Some companies that sought to supply vaccines at lower prices were denied approval while others—friends and associates—were favored. Do you accept this happened, and will you investigate?
Provenance
- Source
- Hansard, Wednesday, 18 December 2024 ·No. 1735286612086554 ·English daily/uncorrected Hansard
- Page · column
- not yet extracted — page/column anchors are not in the current dataset; the source PDF is the citable location.
- Permalink
/lk/speeches/12113
Cite as: The Hon. Rauff Hakeem, Attorney-at-Law. 10th Parliament, Parliament of Sri Lanka. Hansard, 18 December 2024. No. 1735286612086554. Politick, https://staging.politick.io/lk/speeches/12113